Source: BioSpace

Pnuvax: <b>PnuVax</b> To Acquire Inactivated Yellow Fever Vaccine Intellectual Property From GE Healthcare

Life Sciences Jobs ...

Read full article »
Pnuvax's Competitors | Pnuvax's News | Pnuvax's Financials
Stay up-to-date with the latest news on Pnuvax
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Donald Gerson's photo - Founder & CEO of Pnuvax

Founder & CEO

Donald Gerson

CEO Approval Rating

70/100

Read more
Stay up-to-date with the latest news on Pnuvax